7701N Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExtremely low leverage and expanding equity provide durable financial flexibility. This supports investment in R&D, capex, and service networks, cushions downturns, and preserves optionality for strategic moves or shareholder returns without stressing interest coverage or refinancing risk.
Steady Revenue Growth & Improving MarginsConsistent top-line growth with rising gross and operating margins indicates sustainable pricing power and improved operational efficiency. These structural improvements support long-term cash generation and reinvestment capacity, reducing reliance on one-off gains for profitability.
Recurring Revenues And Diversified ProductsA large installed base plus consumables and service contracts creates predictable, higher-margin recurring revenue. Coupled with diversified end-markets (labs, pharma, healthcare, industry), this mix smooths cycles and underpins steady cash flow and lifecycle-driven sales.
Bears Say
Cash Flow Volatility / Working-capital SensitivityYear-to-year swings and operating cash flow that is small relative to revenue indicate working-capital and timing sensitivity. That volatility can constrain reinvestment, dividend stability, or opportunistic M&A, and increases execution risk during industry slowdowns.
Margin Variability Versus Prior HighsObserved margin swings versus peak years suggest exposure to product mix shifts, pricing pressure, or input-cost movements. Persistent variability would limit return on capital improvement and make forward earnings less predictable for planning and long-term investor confidence.
End-market Cyclicality And Capex DependenceRevenue tied to customer capital spending and research budgets makes demand lumpy and sensitive to macro cycles. Longer sales/project timelines and dependence on cyclical capex create structural variability in order flow and utilization, complicating capacity planning.
Shimadzu News
7701N FAQ
What was Shimadzu Corporation’s price range in the past 12 months?
Currently, no data Available
What is Shimadzu Corporation’s market cap?
Shimadzu Corporation’s market cap is $133.55B.
When is Shimadzu Corporation’s upcoming earnings report date?
Shimadzu Corporation’s upcoming earnings report date is Aug 06, 2026 which is in 3 days.
How were Shimadzu Corporation’s earnings last quarter?
Shimadzu Corporation released its earnings results on May 12, 2026. The company reported $8.205 earnings per share for the quarter, beating the consensus estimate of $5.566 by $2.638.
Is Shimadzu Corporation overvalued?
According to Wall Street analysts Shimadzu Corporation’s price is currently Undervalued.
Does Shimadzu Corporation pay dividends?
Shimadzu Corporation does not currently pay dividends.
What is Shimadzu Corporation’s EPS estimate?
Shimadzu Corporation’s EPS estimate is 3.93.
How many shares outstanding does Shimadzu Corporation have?
Shimadzu Corporation has 296,070,250 shares outstanding.
What happened to Shimadzu Corporation’s price movement after its last earnings report?
Shimadzu Corporation reported an EPS of $8.205 in its last earnings report, beating expectations of $5.566. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Shimadzu Corporation?
Currently, no hedge funds are holding shares in MX:7701N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Shimadzu Corporation
Shimadzu Corporation, founded in Kyoto, Japan, in 1875, is a global entity specializing in the development, production, and distribution of a diverse range of advanced instruments and systems. The company's extensive offerings span analytical and measuring instruments, medical systems, industrial machinery, and aviation equipment. Its analytical instrumentation segment provides comprehensive solutions including gas and liquid chromatography, gas and liquid chromatograph-mass spectrometry, molecular and elemental spectroscopy, and surface analysis. This division also manufactures life science laboratory instruments, total organic carbon analyzers, continuous monitoring analysis systems, thermal and particle size analysis equipment, materials testing and inspection devices, non-destructive testing apparatus, and precision balances, all supported by data management software. In the medical sector, Shimadzu delivers cutting-edge imaging technologies such as angiography, fluoroscopy, mobile C-arms, radiography and mobile X-ray systems, and fluorescence imaging products. The company further produces high-precision optical components, including diffraction gratings, aspherical mirrors, specialized laser mirrors and windows for high-power applications, polka-dot beam splitters, and accurate refractometers. For industrial use, Shimadzu offers machinery ranging from turbo molecular pumps, helium leak detectors, sputtering and multi-deposition systems, and vacuum heat-treatment furnaces. Their industrial portfolio also includes liquid delivery gear pumps, mechatronic systems like glass fiber winders and liquid crystal injection systems, and dynamic balancing machines, alongside hydraulic equipment such as hydraulic gear pumps, power packages, and multi-control valves. Additionally, the company supplies the aerospace industry with essential components including electro-mechanical actuators, advanced flight control systems, and landing gear systems.